|
1
|
Zhang QL and Rothenbacher D: Prevalence of
chronic kidney disease in population-based studies: Systematic
review. BMC Public Health. 8:1172008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nugent RA, Fathima SF, Feigl AB and Chyung
D: The burden of chronic kidney disease on developing nations: A
21st century challenge in global health. Nephron Clin Pract.
118:c269–c277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eknoyan G, Lameire N, Barsoum R, et al:
The burden of kidney disease: Improving global outcomes. Kidney
Int. 66:1310–1314. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang L, Wang F, Wang L, Wang W, Liu B,
Liu J, Chen M, He Q, Liao Y, Yu X, et al: Prevalence of chronic
kidney disease in China: A cross-sectional survey. Lancet.
379:815–822. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coresh J, Selvin E, Stevens LA, Manzi J,
Kusek JW, Eggers P, Van Lente F and Levey AS: Prevalence of chronic
kidney disease in the United States. JAMA. 298:2038–2047. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hallan SI, Coresh J, Astor BC, Asberg A,
Powe NR, Romundstad S, Hallan HA, Lydersen S and Holmen J:
International comparison of the relationship of chronic kidney
disease prevalence and ESRD risk. J Am Soc Nephrol. 17:2275–2284.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sarnak MJ, Levey AS, Schoolwerth AC,
Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL,
Kelepouris E, Klag MJ, et al: American Heart Association Councils
on Kidney in Cardiovascular Disease, High Blood Pressure Research,
Clinical Cardiology, and Epidemiology and Prevention: Kidney
disease as a risk factor for development of cardiovascular disease:
A statement from the American Heart Association Councils on Kidney
in Cardiovascular Disease, High Blood Pressure Research, Clinical
Cardiology, and Epidemiology and Prevention. Hypertension.
42:1050–1065. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weiner DE, Tighiouart H, Amin MG, Stark
PC, MacLeod B, Griffith JL, Salem DN, Levey AS and Sarnak MJ:
Chronic kidney disease as a risk factor for cardiovascular disease
and all-cause mortality: A pooled analysis of community-based
studies. J Am Soc Nephrol. 15:1307–1315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Satko SG, Sedor JR, Iyengar SK and
Freedman BI: Familial clustering of chronic kidney disease. Semin
Dial. 20:229–236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tamm I and Horsfall FL Jr:
Characterization and separation of an inhibitor of viral
hemagglutination present in urine. Proc Soc Exp Biol Med.
74:106–108. 1950. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hart TC, Gorry MC, Hart PS, et al:
Mutations of the UMOD gene are responsible for medullary cystic
kidney disease 2 and familial juvenile hyperuricaemic nephropathy.
J Med Genet. 39:882–892. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Padmanabhan S, Melander O, Johnson T, Di
Blasio AM, Lee WK, Gentilini D, Hastie CE, Menni C, Monti MC,
Delles C, et al: Global BPgen Consortium: Genome-wide association
study of blood pressure extremes identifies variant near UMOD
associated with hypertension. PLoS Genet. 6:e10011772010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Köttgen A, Pattaro C, Böger CA,
Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith
AV, et al: New loci associated with kidney function and chronic
kidney disease. Nat Genet. 42:376–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Köttgen A, Glazer NL, Dehghan A, Hwang SJ,
Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, et al:
Multiple loci associated with indices of renal function and chronic
kidney disease. Nat Genet. 41:712–717. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Levey AS, Coresh J, Balk E, Kausz AT,
Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J and Eknoyan
GNational Kidney Foundation: National Kidney Foundation practice
guidelines for chronic kidney disease: Evaluation, classification
and stratification. Ann Intern Med. 139:137–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Levey AS, Bosch JP, Lewis JB, Greene T,
Rogers N and Roth D: Modification of Diet in Renal Disease Study
Group: A more accurate method to estimate glomerular filtration
rate from serum creatinine: A new prediction equation. Ann Intern
Med. 130:461–470. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schrier RW, McFann KK and Johnson AM:
Epidemiological study of kidney survival in autosomal dominant
polycystic kidney disease. Kidney Int. 63:678–685. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rindler MJ, Naik SS, Li N, Hoops TC and
Peraldi MN: Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a
phosphatidylinositol-linked membrane protein. J Biol Chem.
265:20784–20789. 1990.PubMed/NCBI
|
|
19
|
Kreft B, Jabs WJ, Laskay T, et al:
Polarized expression of Tamm-Horsfall protein by renal tubular
epithelial cells activates human granulocytes. Infect Immun.
70:2650–2656. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
El-Achkar TM, Wu XR, Rauchman M, McCracken
R, Kiefer S and Dagher PC: Tamm-Horsfall protein protects the
kidney from ischemic injury by decreasing inflammation and altering
TLR4 expression. Am J Physiol Renal Physiol. 295:F534–F544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sejdiu I and Torffvit O: Decreased urinary
concentration of Tamm-Horsfall protein is associated with
development of renal failure and cardiovascular death within 20
years in type 1 but not in type 2 diabetic patients. Scand J Urol
Nephrol. 42:168–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zaucke F, Boehnlein JM, Steffens S,
Polishchuk RS, Rampoldi L, Fischer A, Pasch A, Boehm CW, Baasner A,
Attanasio M, et al: Uromodulin is expressed in renal primary cilia
and UMOD mutations result in decreased ciliary uromodulin
expression. Hum Mol Genet. 19:1985–1997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prajczer S, Heidenreich U, Pfaller W,
Kotanko P, Lhotta K and Jennings P: Evidence for a role of
uromodulin in chronic kidney disease progression. Nephrol Dial
Transplant. 25:1896–1903. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gudbjartsson DF, Holm H, Indridason OS,
Thorleifsson G, Edvardsson V, Sulem P, de Vegt F, d'Ancona FC, den
Heijer M, Wetzels JF, et al: Association of variants at UMOD with
chronic kidney disease and kidney stones-role of age and comorbid
diseases. PLoS Genet. 6:e10010392010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagasawa Y, Yamamoto R, Rakugi H and Isaka
Y: Cigarette smoking and chronic kidney diseases. Hypertens Res.
35:261–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Daumit GL, Hermann JA and Powe NR:
Relation of gender and health insurance to cardiovascular procedure
use in persons with progression of chronic renal disease. Med Care.
38:354–365. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsu CY, Iribarren C, McCulloch CE,
Darbinian J and Go AS: Risk factors for end-stage renal disease:
25-year follow-up. Arch Intern Med. 169:342–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Neugarten J and Golestaneh L: Gender and
the prevalence and progression of renal disease. Adv Chronic Kidney
Dis. 20:390–395. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zalba G, Fortuño A and Díez J: Oxidative
stress and atherosclerosis in early chronic kidney disease. Nephrol
Dial Transplant. 21:2686–2690. 2006. View Article : Google Scholar : PubMed/NCBI
|
